Premium
Immobilization of Actively Thromboresistant Assemblies on Sterile Blood‐Contacting Surfaces
Author(s) -
Qu Zheng,
Krishnamurthy Venkat,
Haller Carolyn A.,
Dorr Brent M.,
Marzec Ulla M.,
Hurst Sawan,
Hinds Monica T.,
Hanson Stephen R.,
Liu David R.,
Chaikof Elliot L.
Publication year - 2014
Publication title -
advanced healthcare materials
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.288
H-Index - 90
eISSN - 2192-2659
pISSN - 2192-2640
DOI - 10.1002/adhm.201300110
Subject(s) - thrombomodulin , point of care , heparin , computer science , mutant , nanotechnology , biomedical engineering , chemistry , materials science , medicine , surgery , biochemistry , gene , platelet , pathology , immunology , thrombin
Rapid one‐step modification of thrombomodulin with alkylamine derivatives such as azide, biotin, and PEG is achieved using an evolved sortase (eSrtA) mutant. The feasibility of a point‐of‐care scheme is demonstrated herein to site‐specifically immobilize azido‐thrombomodulin on sterilized commercial ePTFE vascular grafts, which exhibit superior thromboresistance compared with commercial heparin‐coated grafts in a primate model of acute graft thrombosis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom